Researchers discovered that GPR21 inhibition improves insulin sensitivity and energy expenditure in mice with obesity. The absence of GPR21 also reduces inflammation and decreases body weight under normal diet conditions. Additionally, another study found that FOXO1 plays a critical role in regulating energy balance and glucose metabol...
Researchers found that deleting GPR21 improves insulin sensitivity in diet-induced obese mice by reducing inflammation. The study suggests that GPR21 inhibitors could be promising treatments for type 2 diabetes.
The study found that two tumor suppressor genes, KLF6 and FOXO1, can disrupt overactive EGFR signaling. By targeting the FOXO1/KLF6 axis, researchers were able to restore effectiveness of anti-EGFR drugs like erlotinib and reduce tumor growth.
A recent clinical trial found that gene therapy can insert the correct ADA gene into patient bone marrow cells, leading to a good response. Defects in B cell tolerance are also corrected after gene therapy, supporting its use as an effective treatment option for ADA-deficient severe combined immunodeficiency patients.
Researchers identified glycerophosphate oxidase as a critical protein for bacterial progression to the brain. A vaccine against this protein protected mice from invasive pneumococcal disease, offering a new approach to immunizing against S. pneumoniae.
Researchers developed a stapled BIM BH3 peptide that competitively binds to anti-apoptotic proteins, leading to enhanced apoptosis in cancer cells. The compound suppresses tumor growth in mice and works synergistically with other pharmaceutical agents.
Researchers developed a new method to identify vaccine targets for Streptococcus pneumoniae, the most common cause of bacterial meningitis. Gene therapy has shown promise in treating adenosine deaminase deficiency by correcting B cell tolerance problems and supporting treatment options for patients with severe combined immunodeficiency.
A mouse model showed that GLO1 activity stimulates GABAA receptors, promoting anxious behavior. Inhibition of GLO1 reduces anxious behavior, suggesting it as a potential novel therapeutic target for anxiety disorders and other CNS diseases.
Research reveals a link between Glyoxylase 1 and increased anxiety in mice, with implications for potential therapeutic targets. Additionally, studies provide hope for new treatments for the rare disease Beare-Stevens syndrome and graft versus host disease.
Researchers developed a new class of compounds that block malaria transmission from humans to mosquitoes by inhibiting bumped kinase I. This approach represents a new strategy for controlling malaria spread. The study's preclinical data in mice suggests the inhibitors are safe and well-tolerated.
Researchers have discovered a new class of malaria transmission-blocking compounds that work by inhibiting bumped kinase I, blocking the parasite's infectious stage. Genetic variation is also linked to high blood pressure, with researchers finding that inhibiting renin pathway activity can return blood pressure to normal levels.
Researchers found that PAX5 stabilizes MYC protein levels in B cells, correlating with poor patient survival. Additionally, STIM1 regulates calcium signaling to control fat preference, while IL-12 production is decreased in diabetic patients with increased infection risk.
Researchers have discovered a CD19-dependent pathway that contributes to the growth of B cell lymphomas. High levels of CD19 correlate with increased MYC activity, suggesting a new target for therapies currently in clinical trials.
Researchers found vitamin D can stimulate bone cells to remove calcium from bones, potentially leading to density loss and increased fracture risk. This discovery may explain conflicting results of clinical trials examining the effects of vitamin D supplements on preventing fractures in elderly patients.
Researchers found vitamin D can promote bone density loss while maintaining normal serum calcium levels. The study suggests vitamin D supplements may not be effective in preventing fractures in elderly patients, and high doses could even increase fracture risk.
Researchers found that HIV-1 replication in human tissues increases with a single amino acid change in the Gag protein. This adaptation is crucial for efficient viral replication and may have played a role in the emergence of HIV/AIDS.
Researchers study the origins of HIV/AIDS, revealing that SIV replication in human tissues is crucial to viral efficiency. In contrast, a new study finds that autoantibodies against citrullinated proteins contribute to bone loss in rheumatoid arthritis patients.
Researchers have made significant advancements in treating autoimmune diabetes by harnessing the power of gut bacteria. Additionally, studies on cancer treatment and tumor growth have revealed that vascular normalization can prevent dangerous side effects while enhancing anti-tumor effects. Furthermore, scientists have discovered a coo...
Researchers have made a breakthrough in treating autoimmune diabetes using genetically modified gut bacteria, increasing the frequency of cured mice compared to traditional methods. The new approach has no adverse side effects and allows the immune system to function normally.
A new study found that a protein called SIX1 plays a critical role in early stage metastasis, especially lymphatic metastasis, in breast cancer. The study identified the SIX1-VEGF-C pathway as an important signaling pathway involved in breast cancer metastasis.
Researchers discovered a novel signaling pathway involving SIX1 and VEGF-C that plays a crucial role in breast cancer metastasis. The study showed that this pathway can be targeted to develop new anti-cancer therapies.
Research suggests a connection between insulin resistance and Alzheimer's disease, with defective insulin signaling potentially impacting cognitive function. Studies show that treating Alzheimer's disease with anti-diabetic drugs can normalize insulin signaling and improve cognitive function.
Research published in JCI suggests a connection between insulin resistance and Alzheimer's disease, highlighting potential new therapeutics for treatment. The studies found that defective insulin signaling is a common feature of Alzheimer's disease and that treatment with a new anti-diabetic drug normalized insulin signaling and improv...
Researchers discovered that radiation treatment inhibits monocyte entry into the optic nerve head, preventing neuronal damage in a mouse model of glaucoma. This breakthrough sheds light on a potential prevention strategy for glaucoma, which is one of the leading causes of vision loss and blindness worldwide.
A new study has shed light on glaucoma prevention by highlighting the impact of X-ray treatment on monocyte entry into the optic nerve. Researchers found that mice treated with a single X-ray treatment prior to glaucoma onset were protected from developing the disease, even with other risk factors.
Researchers at the University of Southern California have identified the role of stem and progenitor cells in liver regeneration. Bone marrow-derived progenitor cells were found to be required for liver regeneration following surgical removal, shedding light on liver complications associated with suppressed bone marrow tissue.
A study found that bone marrow-derived progenitor cells promote liver regeneration in rats, improving our understanding of how liver tissue can regenerate following damage. Researchers also discovered a new determinant of human breast cancer metastasis, highlighting the potential for new therapeutics targeting this pathway.
Researchers have found that Plexin-B1 represents a new candidate therapeutic target to treat patients with breast cancer found to overexpress the molecule ErbB-2. Overexpression of ErbB-2 led to activation of Plexin-B1, promoting metastatic cell characteristics in human breast cancer cells and reducing prognosis in human patients.
A team of researchers identified a beta-1 integrin signaling pathway crucial for HNSCC resistance to radiotherapy. Inhibiting this pathway sensitized cells to radiation and delayed tumor growth in mice.
Scientists discover Plexin-B1 as a potential therapeutic target for ErbB-2-overexpressing breast cancers, which have high metastatic potential. Additionally, researchers find that blocking the ErbB-2/Plexin-B1 interaction may reduce the risk of metastasis in patients with this type of cancer. In another study, researchers identify a be...
Research identifies increased expression of Dyrk1a as a potential explanation for the increased risk of acute megakaryoblastic leukemia (AMKL) in children with Down syndrome. A candidate therapeutic target, small-molecule inhibitors of DYRK1A activity, have been proposed.
Researchers have discovered that mutations in the MCM4 gene are responsible for a complex inherited condition affecting adrenal glands, growth, and immune cells in the Irish Traveller community. The findings provide deep insight into DNA replication and genomic instability, potentially increasing cancer risk.
A study in a mouse model of Down syndrome identifies increased expression of protein Dyrk1a as a promoter of acute megakaryoblastic leukemia, offering a candidate therapeutic target for treatment.
Researchers have discovered a new way to enhance trastuzumab treatment in HER2-positive breast cancer patients by stimulating natural killer cells. Additionally, the activation of FoxO1 has been linked to the development of diabetic cardiomyopathy, offering a promising therapeutic target. Leptin's direct action on POMC neurons may also...
Researchers at Stanford University have identified a sequential treatment regimen that enhances the effectiveness of trastuzumab in xenotransplant models of breast cancer. Trastuzumab activates natural killer cells to kill HER2-overexpressing tumor cells.
Researchers identify FoxO1 as critical for diabetic cardiomyopathy development, suggesting a promising therapeutic target. Activation of FoxO1 in mice with type 2 diabetes models triggers cardiomyopathy, highlighting the need for new treatments to address this leading cause of death in diabetics.
Research by Sheila Collins and colleagues found that cardiac natriuretic peptides cause white fat cells to take on characteristics of brown fat cells, increasing energy usage. In another study, Anne Müller's team identified a cellular mechanism by which Helicobacter pylori protects against asthma by modulating immune cells.
Researchers discovered that cardiac natriuretic peptides can convert white fat cells into brown fat cells in mice and humans, increasing energy usage and potentially aiding in weight loss. The study suggests a new approach to combating the obesity epidemic.
A team of researchers has identified a potential new therapeutic target for the treatment of glioblastoma multiforme (GBM), a highly aggressive form of brain cancer. They found that protein SULF2 is expressed in primary human GBM tumors and cell lines, and its expression is associated with abnormal activation of signaling pathways down...
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor resistant to current therapies. Researchers at the University of California, San Francisco, have identified PDGFR-alpha and SULF2 as potential therapeutic targets for GBM treatment. Knocking down SULF2 expression decreased cell growth in human GBM cell lines.
Neural stem cell derivatives from human pluripotent stem cells are prone to chromosomal instability, particularly with chromosome 1q, which has been linked to blood cell cancers and pediatric brain tumors.
A team of researchers found that brown fat in adult men burns energy to generate body heat when exposed to cold temperatures, but not at warm temperatures. This discovery has significant implications for the human obesity epidemic, suggesting that increasing brown fat is unlikely to lead to weight loss and instead highlights the need f...
Researchers have found that brown fat in healthy adult men burns energy to generate body heat during cold exposure, but not at warm temperatures. This discovery has significant implications for combating the human obesity epidemic and suggests that increasing brown fat may not lead to weight loss.
Researchers discovered that topical application of imiquimod recruits plasmacytoid DCs to the tumor site, converting them into tumor-killing effector cells. A new mechanism for IFN-alpha suppression was also identified, targeting epigenetic regulation of nuclear cccDNA minichromosome.
Researchers found that imiquimod converts plasmacytoid DCs into tumor-killing effector cells, clearing tumors in a mouse model of melanoma. This discovery has implications for antitumor therapies targeting both skin cancers and other types.
Researchers identified genetic mutations in OATP1B1 and OATP1B3 proteins as the underlying cause of Rotor syndrome, a condition characterized by conjugated bilirubin buildup. Complete deficiency of these proteins can cause hypersensitivity to certain drugs and interrupt conjugated bilirubin reuptake into the liver.
A team of researchers has associated mutations in the reticulon 2 gene with hereditary spastic paraplegia type 12. They discovered that these mutations likely cause neurodegeneration by disrupting ER-shaping proteins, providing new insights into this complex disorder.
A team of researchers identified genetic mutations in OATP1B1 and OATP1B3 as the cause of Rotor syndrome, a rare genetic disorder characterized by jaundice. Complete deficiency of these proteins causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.
Researchers identify CCL5/CCR5 interaction as key to recruiting endothelial progenitor cells for wound healing. Mice with faulty CCR5 show delayed healing, suggesting similar issues in humans with CCR5 mutations.
Scientists identify chemokine CCL5 as a crucial signal for endothelial progenitor cell recruitment in wound healing. Meanwhile, researchers discover CBX7 acts as a tumor suppressor, regulating cell growth and preventing cancer progression. Additionally, zinc deficiency is linked to severe skin inflammation due to impaired immune functi...